Gene: TMOD2
Official Full Name: tropomodulin 2provided by HGNC
Gene Summary: This gene encodes a neuronal-specific member of the tropomodulin family of actin-regulatory proteins. The encoded protein caps the pointed end of actin filaments preventing both elongation and depolymerization. The capping activity of this protein is dependent on its association with tropomyosin. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27049 | TMOD2 Knockout cell line (HeLa) | Human | TMOD2 | 1:3~1:6 | Negative | Online Inquiry |
KO27050 | TMOD2 Knockout cell line (HCT 116) | Human | TMOD2 | 1:2~1:4 | Negative | Online Inquiry |
KO27051 | TMOD2 Knockout cell line (HEK293) | Human | TMOD2 | 1:3~1:6 | Negative | Online Inquiry |
KO27052 | TMOD2 Knockout cell line (A549) | Human | TMOD2 | 1:3~1:4 | Negative | Online Inquiry |
TMOD2 Gene Knockout Cell Lines are engineered cellular models specifically designed to study the function and regulation of the TMOD2 gene, which encodes a tropomodulin protein involved in the stabilization of actin filament structures in various cell types. This product utilizes CRISPR/Cas9 technology to effectively disrupt the TMOD2 gene, resulting in a loss-of-function phenotype that allows researchers to investigate the biological consequences of TMOD2 deficiency on cellular processes such as motility, proliferation, and signaling pathways associated with cytoskeletal dynamics.
Key mechanisms through which these knockout cell lines operate include alterations in actin filament architecture, leading to changes in cell shape and locomotion. By employing these TMOD2 knockout cell lines, researchers can elucidate the specific pathways affected by the absence of TMOD2 proteins, advancing our understanding of cellular diseases and developmental processes where actin dynamics is critical.
The scientific importance of TMOD2 Gene Knockout Cell Lines extends to their application in both basic and translational research. In clinical settings, studying these cell lines can provide insights into disorders associated with actin cytoskeletal dysfunction, including muscular dystrophies and cancer metastasis. Furthermore, these models serve as an invaluable tool in drug discovery, as they enable the identification of novel therapeutic targets by clarifying the roles of TMOD2 in various physiological and pathological contexts.
What sets our TMOD2 Gene Knockout Cell Lines apart from traditional models is their high specificity and efficiency, coupled with the precision afforded by CRISPR-based manipulation. Unlike wild-type cell lines, these knockouts offer a clearer and more controlled environment for observing the direct effects of gene ablation without the confounding results from endogenous gene expression.
For researchers, clinicians, and biotechnology companies, the TMOD2 Gene Knockout Cell Lines are an essential addition to any laboratory's toolkit, providing a robust model system for innovative research and development. Backed by our extensive expertise in cellular engineering and molecular biology, we deliver not just high-quality products but also comprehensive support to ensure your research endeavors are successful.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.